目录
查看完整图片 — 免费注册
使用Google继续 — 免费
或用邮箱注册
为什么需要注册？只是为了防止机器人访问我们的目录。您的邮箱完全保密——我们绝不会分享或在未经您许可的情况下发送任何内容。我们向您保证！
| 正面描述 | 登录 以查看详情 |
|---|---|
| 正面铭文 | 登录 以查看详情 |
| 背面描述 | The reverse is devoted to the theme of medical innovation. At centre, a vignette shows a researcher in a laboratory coat working at a microscope modelled on the Carl Zeiss Axioplan 2, with a DNA double-helix strand rendered to its right. Below the central vignette runs an electrocardiogram trace, beside which an early insulin bottle is placed, referencing one of Canada's most celebrated medical contributions. At left, the denomination and a mirrored reflection of the holographic strip are visible, while at right the reverse face of the maple leaf-shaped transparent window appears with the denomination below. |
| 背面铭文 | 100 Canada INNOVATION MÉDICALE MEDICAL INNOVATION INSULIN INSULINE 100 |
| 签名 | 登录 以查看详情 |
| 防伪类型 | 登录 以查看详情 |
| 防伪描述 | 登录 以查看详情 |
| 变体 | 登录 以查看详情 |
| 备注 |
The 2011 polymer series marked a significant production shift for the Bank of Canada — moving away from cotton-rag paper stock that had defined Canadian currency for over a century. The $100 was the first denomination released in November 2011, ahead of the lower values, a deliberate sequencing choice driven by counterfeiting risk. Early distribution was plagued by complaints that notes stuck together in cold weather and became brittle; the Bank acknowledged the issue and attributed it to handling technique rather than a manufacturing defect, a response that satisfied almost nobody.
Printed by the Canadian Bank Note Company in Ottawa, the series introduced a large transparent window with a laser-etched element — at the time among the more technically demanding security features in North American circulation.